Ir diretamente para o conteúdo
HPB-ALL
Tecido
Peripheral blood
Doença
Precursor T-cell acute lymphoblastic leukemia
Local da metástase
Peripheral blood (systemic T-ALL)
Sinónimos
HPB/ALL, HPBALL, FCCH1018

Documentos

HPB-ALL

Cell line · Número do produto 302895

A HPB-ALL é uma linha celular de leucemia linfoblástica aguda de células T precursoras humanas (T-ALL) isolada do sangue periférico de um doente japonês do sexo masculino, com 14 anos de idade...

€430.00sem impostos nem portes de envio

Personalização / Recomendações

Em stock
Lote
Recomendado (lote mais recente)
  • CoA
1

01Informações gerais

Descrição

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Tecido
Peripheral blood
Doença
Precursor T-cell acute lymphoblastic leukemia
Local da metástase
Peripheral blood (systemic T-ALL)
Aplicações
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinónimos
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Classificação

Organismo
Humano
Sexo
Masculino
Propriedades de crescimento
Suspensão
Nível de biossegurança
1

03Características

Morfologia
Lymphoblast-like
Tipo de célula
T-cell
Tempo de duplicação
~50 hours

04Identificadores

Referência
HPB-ALL (Cytion catalog number 302895)
Número de identificação fiscal do NCBI
9606
Cellosaurus
CVCL_1820

05Expressão e suscetibilidade

Perfil mutacional
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Manuseamento e cultura

Meio de cultura
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Suplementos
Supplement the medium with 10% FBS
Reagente de dissociação
dilution
Subcultura
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Rácio de divisão
1 : 10 split
Densidade de sementeira
3-5*10^5/ml
Renovação de fluidos
Subculture : 2 times/week
Descongelamento e cultura
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Controlo de qualidade e criopreservação

Meio de congelação
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condições de armazenamento

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Condições de envio

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Doador

Idade do dador
14 years
Etnia
Japanese

10Detalhes do produto

Tabela de composição